CORC

在结果中检索

CORC

浏览/检索结果: 共42条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
PAX8 is Expressed in Less Than Half of Anaplastic Thyroid Carcinomas - Multi-Institutional Study Using Monoclonal Antibody MRQ-50 会议论文
108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity, MAR 16-21, 2019
作者:  Bai, Yanhua;  Liu, Zhiyan;  Gu, Haiyan;  Jung, Chan Kwon;  Hang, Jen-Fan
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/31
PAX8 is Expressed in Less Than Half of Anaplastic Thyroid Carcinomas - Multi-Institutional Study Using Monoclonal Antibody MRQ-50 会议论文
108th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) - Unlocking Your Ingenuity, MAR 16-21, 2019
作者:  Bai, Yanhua;  Liu, Zhiyan;  Gu, Haiyan;  Jung, Chan Kwon;  Hang, Jen-Fan
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/31
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced gastric adenocarcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study 会议论文
作者:  Xu, Rui-hua;  Wang, Fenghua;  Xu, Nong;  Shen, Lin;  Dai, Guanghai
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study 会议论文
作者:  Xu, Rui-hua;  Wang, Fenghua;  Shi, Jianhua;  Feng, Ji Feng;  Shen, Lin
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced gastric adenocarcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study 会议论文
作者:  Xu, Rui-hua;  Wang, Fenghua;  Xu, Nong;  Shen, Lin;  Dai, Guanghai
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
Efficacy, safety, and pharmacokinetics of the anti-programmed cell death receptor-1 (PD-1) monoclonal antibody, tislelizumab (BGB-A317) in a phase 2, open-label, multicenter study to investigate in patients with unresectable hepatocellular carcinoma - Trial in progress 会议论文
作者:  Ren, Z.;  Assenat, E.;  Cubillo, A.;  Pluntke, S.;  Rimassa, L.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) in patients with refractory/metastatic nasopharyngeal carcinoma: Preliminary results of an open-label phase II clinical study 会议论文
作者:  Xu, R.;  Wang, F. H.;  Feng, F. J.;  Li, Q.;  Xu, N.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Preliminary safety, pharmacokinetics (PK) and efficacy results from a phase I study of CS1001, an anti-programmed death ligand-1 (PD-L1) monoclonal antibody (mAb) in patients (pts) with advanced tumors 会议论文
作者:  Shen, L.;  Cao, J.;  Gong, J.;  Ji, D.;  Qin, Z.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study 会议论文
作者:  Xu, Rui-hua;  Wang, Fenghua;  Shi, Jianhua;  Feng, Ji Feng;  Shen, Lin
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Recombinant humanised anti-PD-1 monoclonal antibody (JS001) treatment for patients with refractory or metastatic nasopharyngeal carcinoma: preliminary results of an open-label, phase 1b/2, clinical study 会议论文
作者:  Xu, Ruihua;  Wang, Fenghua;  Li, Qi;  Shi, Jianhua;  Shen, Lin
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace